Standardized classification schemes in reporting oncologic PET/CT

Vanessa Murad; Roshini Kulanthaivelu; Claudia Ortega; Patrick Veit-Haibach; Ur Metser

doi:10.3389/fmed.2022.1051309

Standardized classification schemes in reporting oncologic PET/CT

Front Med (Lausanne). 2023 Jan 26:9:1051309. doi: 10.3389/fmed.2022.1051309. eCollection 2022.

Authors

Vanessa Murad^{1

2}, Roshini Kulanthaivelu^{1

2}, Claudia Ortega^{1

2}, Patrick Veit-Haibach^{1

2}, Ur Metser^{1

2}

Affiliations

¹ Molecular Imaging Division, Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, ON, Canada.
² University Medical Imaging Toronto, University of Toronto, Toronto, ON, Canada.

Abstract

The imaging report is essential for the communication between physicians in patient care. The information it contains must be clear, concise with evidence-based conclusions and sufficient to support clinical decision-making. In recent years, several classification schemes and/or reporting guidelines for PET have been introduced. In this manuscript, we will review the classifications most frequently used in oncology for interpreting and reporting ¹⁸F-FDG PET imaging in lymphoma, multiple myeloma, melanoma and head and neck cancers, PSMA-ligand PET imaging for prostate cancer, and ⁶⁸Ga-DOTA-peptide PET in neuroendocrine tumors (NET).

Keywords: Deauville; Krenning; PET; PROMISE; head and neck cancer; immunotherapy.

Publication types

Review